-
CONFERENCE PDF
POSTER
Re-evaluation of resistance algorithms for lopinavir/ritonavir in the TITAN
trial
A Hill, A-G Marcelin, V Calvez, et al 2008 International
HIV Drug Resistance Workshop
-
CONFERENCE PDF
POSTER
Comparable in-vitro susceptibility and virological outcome to
darunavir in patients infected
with subtype B and non-subtype B HIV isolates participating in the
ARTEMIS Phase III trial
I Dierynck, SDe Meyer, E Lathouwers, et al
2008 International
HIV Drug Resistance Workshop
-
CONFERENCE PDF
POSTER
Phenotypic and genotypic determinants of resistance to darunavir:
analysis of data from
treatment-experienced patients in POWER 1, 2, 3 and DUET-1 and
DUET-2
S De Meyer, I Dierynck, E Lathouwers, et al
2008 International
HIV Drug Resistance Workshop
-
Virological response to darunavir/ritonavir-based regimens in
antiretroviral-experienced patients (PREDIZISTA study).
Pellegrin I, Wittkop L, Joubert LM, et al Antivir Ther. 2008;13(2):271-9.
-
Follow-up of a multi-drug resistant HIV-1 infected patient
successfully treated with darunavir and etravirine.
Audelin AM, Lebech AM, Petersen AB, Jørgensen LB.
J Med Virol. 2008 Jun 12;80(8):1319-1321.
|
New
and Noteworthy
Protease
Inhibitors: General Data
ARV
Drugs Main Page
Documents
identified with this icon are in Portable Document Format (PDF) and require the
US
Treatment Guidelines
